New post on these "groundbreaking new chemo agents" - are they really as good as advertised?
Jason Demuth, Pharmacist
Friday, October 30, 2015
Friday, October 23, 2015
Jerry's kids get some hope
Jason Demuth, Pharmacist
New treatments in the pipeline for MD. I hope Jerry's kids get some hope and one of these treatments saves some lives!
New treatments in the pipeline for MD. I hope Jerry's kids get some hope and one of these treatments saves some lives!
Tuesday, October 20, 2015
Sunday, October 18, 2015
Pradaxa reversal agent
https://jasondemuthpharmacist.wordpress.com/2015/10/18/could-pradaxa-get-their-momentum-going/
This could be what BI needs to jumpstart lagging sales of their NOAC. Not sure of PraxBind pricing, but estimating it in the thousands of dollars.
This could be what BI needs to jumpstart lagging sales of their NOAC. Not sure of PraxBind pricing, but estimating it in the thousands of dollars.
Friday, October 16, 2015
Price jumps!! someone finally looking at this
jason demuth, pharmacist
Well, it took election coverage and outrage from presidential coverage.... but someone is finally looking at the huge price hikes for previously inexpensive medications. This concerns two generic injectable critical care medicines. Both are low volume, but when you see a price jump from $50/vial to $700/vial - pharmacy budgets take notice. The problem starts when a lower volume, inexpensive injectable loses manufacturers and leaves someone with a monopoly. Then they are free to raise prices figuring they have margin to gain, and little volume to lose. If this was a one-off case maybe it wouldn't matter, but now that more and more meds are being hiked it is lawyers are beginning to notice. Now that Pfizer is also in the generic drug market, don't expect this trend to stop anytime soon.
Well, it took election coverage and outrage from presidential coverage.... but someone is finally looking at the huge price hikes for previously inexpensive medications. This concerns two generic injectable critical care medicines. Both are low volume, but when you see a price jump from $50/vial to $700/vial - pharmacy budgets take notice. The problem starts when a lower volume, inexpensive injectable loses manufacturers and leaves someone with a monopoly. Then they are free to raise prices figuring they have margin to gain, and little volume to lose. If this was a one-off case maybe it wouldn't matter, but now that more and more meds are being hiked it is lawyers are beginning to notice. Now that Pfizer is also in the generic drug market, don't expect this trend to stop anytime soon.
Wednesday, October 14, 2015
Pharmacy inspector advice
jason demuth, pharmacist
Good advice from a former FDA inspector - KEEP YOUR MOUTH SHUT! Answer the question and do not elaborate.
Good advice from a former FDA inspector - KEEP YOUR MOUTH SHUT! Answer the question and do not elaborate.
Thursday, October 8, 2015
Vaccine for resistant bug
jason demuth, pharmacist
Resistance in bacteria, viruses, and fungus has been increasing rapidly over the last decade. This is costing tens of thousands of lives every year that previously would have been cured. We are losing the race to develop new and novel antibiotics. Vaccines have the potential to reverse this trend.
Resistance in bacteria, viruses, and fungus has been increasing rapidly over the last decade. This is costing tens of thousands of lives every year that previously would have been cured. We are losing the race to develop new and novel antibiotics. Vaccines have the potential to reverse this trend.
Subscribe to:
Comments (Atom)